Ascendis to share rare endocrinology program data at ESPE 2026
Ascendis Pharma A/S said it will share the latest Endocrinology Rare Disease program data during ESPE 2026, the European Society for Paediatric Endocrinology’s annual congress on September 8.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.